ClinicalTrials.gg
RecruitingNCT07561697Updated May 1, 2026

Percutaneous Achilles Tendon Tenotomy vs Tendo-Achilles Lengthening (TAL) in Neglected Clubfoot Children.

An observational study in Clubfoot, sponsored by Muhammad Aamir Latif. Recruiting at 1 site in Pakistan. Open to participants aged 2 Years to 5 Years. Per ClinicalTrials.gov, last updated 2026-05-01.

Sponsored by Muhammad Aamir Latif · Observational

From the registry’s dates

  • Primary completion was expected by Apr 2026, 6 months ago, but the record still lists the study as recruiting.
  • Started Aug 2025; still recruiting 1 year 2 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
44
Ages
2 Years to 5 Years
Sex
All
01

Study summary

Achilles tendon tenotomy is the established worldwide gold standard for correcting idiopathic clubfoot. However, in neglected cases, surgical interventions such as percutaneous Achilles tendon tenotomy (PAT) and open tendo-Achilles lengthening (TAL) are common techniques for correcting this deformity. This study aimed at determining the functional outcomes of Percutaneous Achilles Tendon Tenotomy (PAT) vs tendo-Achilles Lengthening (TAL) in the neglected clubfoot children of age 2-5 years.

Read the detailed description

Despite the increasing use of percutaneous techniques, there is a lack of literature directly comparing the functional outcomes of these two procedures, PAT and TAL. Addressing this knowledge gap is essential to guide pediatric orthopedic surgeons in selecting the most appropriate intervention for the treatment of equinus deformity in neglected clubfoot patients, optimizing functional recovery, minimizing complications, and ultimately improving the quality of care for children with neglected clubfoot.

02

Conditions studied

  • Clubfoot

Browse trials for

03

In context

Clubfoot

69 studies on the registry are indexed under Clubfoot; 15 are open to participants now.

This study's planned enrollment of 44 is below the median of 55 across 27 observational studies indexed under Clubfoot.

Browse Clubfoot studies →

Lead sponsor

Muhammad Aamir Latif is the lead sponsor of 57 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 5 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Newly diagnosed patients of clubfoot between 2 and 5 years of age having Pirani score 3-6 within the study period will be recruited.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Any gender
  • Aged 2-5 years
  • diagnosed with clubfoot
  • Pirani score 3-6

Exclusion criteria

Exclusion Criteria:

  • Patients with other neuromuscular, chromosomal abnormalities
  • myelomeningocele
  • Dystrophic dysplasia
  • Moebius syndrome
  • Amniotic band syndrome
  • Metatarsus adductus
  • Syndactyly
  • Polydactyly
  • Previously underwent Achilles tendon tenotomy or tendo-Achilles lengthening
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
44 participants (estimated)
Patient registry
No

Groups and cohorts

  • Percutaneous Achilles Tendon Tenotomy-Group

    Patients will be started on serial casting and manipulation according to ponseti method. After successful correction of cavus, varus, and adductus, patients will be treated using the tenotomy of Achilles tendon technique.

    Procedure: Tenotomy of Achilles Tendon

  • Tendo-Achilles Lengthening-Group

    Patients will be started on serial casting and manipulation according to ponseti method. After successful correction of cavus, varus, and adductus, patients will be treated using the tendo-Achilles Lengthening technique.

    Procedure: Tendo-Achilles Lengthening

Interventions

  • ProcedureTenotomy of Achilles Tendon

    Patients will be started on serial casting and manipulation according to ponseti method. After successful correction of cavus, varus, and adductus, patients will be treated using the tenotomy of Achilles tendon technique.

  • ProcedureTendo-Achilles Lengthening

    Patients will be started on serial casting and manipulation according to ponseti method. After successful correction of cavus, varus, and adductus, patients will be treated using the Tendo-Achilles Lengthening technique.

06

What researchers measure

Primary outcomes

  1. Improvement in ankle dorsiflexion

    Frequency of patients with improvement in ankle dorsiflexion will be noted.

    Time frame: 6 months

Secondary outcomes

  1. Bleeding

    Frequencies of bleeding as none, mild moderate, and severe will be noted.

    Time frame: 1 hour

  2. Infection

    Frequency of patients who had an infected wound will be noted.

    Time frame: 6 months

  3. Incomplete tenotomy

    Frequency of patients who will have incomplete release or residual deformity assessed after 6 months.

    Time frame: 6 months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Data can be shared on a reasonable request.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 1, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07561697
Lead sponsor
Muhammad Aamir Latif
Responsible party
Muhammad Aamir Latif (Research Consultant, RESnTEC, Institute of Research) — Sponsor-investigator
First posted
May 1, 2026
Start date
Aug 15, 2025
Primary completion
Apr 30, 2026 (estimated)
Completion
Apr 30, 2026 (estimated)
Last update
May 1, 2026

Study contacts

Pervez Ali, FCPS
Contact
pervez73@hotmail.com
+923333001737
Sidratul Zaitoon
Contact
sidra9503@gmail.com
+923150012163
Pervez Ali, FCPS
study director · Jinnah Postgraduate Medical Centre, Karachi, Pakistan
Sidratul Zaitoon
principal investigator · Jinnah Postgraduate Medical Centre, Karachi, Pakistan

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion